Ledger.Open graph →

SEC Form D · Amendment · filed February 14, 2022

ArriVent Biopharma, Inc

Offering

$150.0M

Sold

$150.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NEWTOWN SQUARE, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jason Zhang · Newtown Square, PADirector Cong Xu · Newtown Square, PADirector Zhengbin (Bing) Yao · Newtown Square, PAExec · Director Stuart Lutzker · Newtown Square, PADirector Jason Zhang · Newtown Square, PADirector Cong Xu · Newtown Square, PADirector Zhengbin (Bing) Yao · Newtown Square, PAExec · Director Stuart Lutzker · Newtown Square, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗